3 research outputs found
Fusion to a highly stable consensus albumin binding domain allows for tunable pharmacokinetics
A new network for the advancement of marine biotechnology in europe and beyond
Marine organisms produce a vast diversity of metabolites with biological activities
useful for humans, e.g., cytotoxic, antioxidant, anti-microbial, insecticidal, herbicidal,
anticancer, pro-osteogenic and pro-regenerative, analgesic, anti-inflammatory, anticoagulant, cholesterol-lowering, nutritional, photoprotective, horticultural or other
beneficial properties. These metabolites could help satisfy the increasing demand for
alternative sources of nutraceuticals, pharmaceuticals, cosmeceuticals, food, feed,
and novel bio-based products. In addition, marine biomass itself can serve as
the source material for the production of various bulk commodities (e.g., biofuels,
bioplastics, biomaterials). The sustainable exploitation of marine bio-resources and
the development of biomolecules and polymers are also known as the growing
field of marine biotechnology. Up to now, over 35,000 natural products have been
characterized from marine organisms, but many more are yet to be uncovered, as
the vast diversity of biota in the marine systems remains largely unexplored. Since
marine biotechnology is still in its infancy, there is a need to create effective, operational,
inclusive, sustainable, transnational and transdisciplinary networks with a serious and
ambitious commitment for knowledge transfer, training provision, dissemination of
best practices and identification of the emerging technological trends through science
communication activities. A collaborative (net)work is today compelling to provide
innovative solutions and products that can be commercialized to contribute to the
circular bioeconomy. This perspective article highlights the importance of establishing
such collaborative frameworks using the example of Ocean4Biotech, an Action within
the European Cooperation in Science and Technology (COST) that connects all and any
stakeholders with an interest in marine biotechnology in Europe and beyond
A New Network for the Advancement of Marine Biotechnology in Europe and Beyond
Marine organisms produce a vast diversity of metabolites with biological activities useful for humans, e.g., cytotoxic, antioxidant, anti-microbial, insecticidal, herbicidal, anticancer, pro-osteogenic and pro-regenerative, analgesic, anti-inflammatory, anti-coagulant, cholesterol-lowering, nutritional, photoprotective, horticultural or other beneficial properties. These metabolites could help satisfy the increasing demand for alternative sources of nutraceuticals, pharmaceuticals, cosmeceuticals, food, feed, and novel bio-based products. In addition, marine biomass itself can serve as the source material for the production of various bulk commodities (e.g., biofuels, bioplastics, biomaterials). The sustainable exploitation of marine bio-resources and the development of biomolecules and polymers are also known as the growing field of marine biotechnology. Up to now, over 35,000 natural products have been characterized from marine organisms, but many more are yet to be uncovered, as the vast diversity of biota in the marine systems remains largely unexplored. Since marine biotechnology is still in its infancy, there is a need to create effective, operational, inclusive, sustainable, transnational and transdisciplinary networks with a serious and ambitious commitment for knowledge transfer, training provision, dissemination of best practices and identification of the emerging technological trends through science communication activities. A collaborative (net)work is today compelling to provide innovative solutions and products that can be commercialized to contribute to the circular bioeconomy. This perspective article highlights the importance of establishing such collaborative frameworks using the example of Ocean4Biotech, an Action within the European Cooperation in Science and Technology (COST) that connects all and any stakeholders with an interest in marine biotechnology in Europe and beyond